USD 31.33
(1.57%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 | 252.92 Million USD | -8.35% |
2023 | 275.97 Million USD | 75.78% |
2022 | 157 Million USD | -25.45% |
2021 | 210.6 Million USD | 66.57% |
2020 | 126.43 Million USD | -8.19% |
2019 | 137.71 Million USD | -37.37% |
2018 | 219.88 Million USD | -23.63% |
2017 | 287.92 Million USD | -17.19% |
2016 | 347.71 Million USD | -6.89% |
2015 | 373.42 Million USD | 8.0% |
2014 | 345.75 Million USD | -2.45% |
2013 | 354.45 Million USD | -0.99% |
2012 | 358 Million USD | -4.79% |
2011 | 376 Million USD | 5.83% |
2010 | 355.29 Million USD | 2.62% |
2009 | 346.22 Million USD | -3.61% |
2008 | 359.2 Million USD | 7.0% |
2007 | 335.69 Million USD | 3.92% |
2006 | 323.01 Million USD | 6.91% |
2005 | 302.13 Million USD | 24.59% |
2004 | 242.5 Million USD | 35.51% |
2003 | 178.94 Million USD | 21.58% |
2002 | 147.18 Million USD | 27.85% |
2001 | 115.11 Million USD | 17.05% |
2000 | 98.34 Million USD | 25.6% |
1999 | 78.3 Million USD | 19.91% |
1998 | 65.3 Million USD | 26.8% |
1997 | 51.5 Million USD | 15.47% |
1996 | 44.6 Million USD | 14.36% |
1995 | 39 Million USD | 21.12% |
1994 | 32.2 Million USD | 58.62% |
1993 | 20.3 Million USD | 50.37% |
1992 | 13.5 Million USD | 19.47% |
1991 | 11.3 Million USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 38.22 Million USD | -63.64% |
2024 FY | 252.92 Million USD | -8.35% |
2024 Q4 | 87.78 Million USD | 20.06% |
2024 Q3 | 73.12 Million USD | 28.5% |
2024 Q2 | 56.9 Million USD | 48.87% |
2023 Q2 | 60.09 Million USD | 72.47% |
2023 Q3 | 57.81 Million USD | -3.8% |
2023 Q1 | 34.84 Million USD | -52.16% |
2023 FY | 275.97 Million USD | 75.78% |
2023 Q4 | 105.11 Million USD | 81.82% |
2022 Q1 | -39.52 Million USD | -205.84% |
2022 FY | 157 Million USD | -25.45% |
2022 Q4 | 72.83 Million USD | 19.73% |
2022 Q3 | 60.83 Million USD | -3.22% |
2022 Q2 | 62.86 Million USD | 259.02% |
2021 FY | 210.6 Million USD | 66.57% |
2021 Q1 | 37.87 Million USD | 106.16% |
2021 Q4 | 37.34 Million USD | -39.45% |
2021 Q3 | 61.68 Million USD | -16.31% |
2021 Q2 | 73.7 Million USD | 94.62% |
2020 Q4 | -614.46 Million USD | -1502.37% |
2020 Q2 | -18.14 Million USD | -208.83% |
2020 FY | 126.43 Million USD | -8.19% |
2020 Q1 | 16.67 Million USD | -64.24% |
2020 Q3 | 43.81 Million USD | 341.46% |
2019 Q1 | 4.51 Million USD | -89.06% |
2019 FY | 137.71 Million USD | -37.37% |
2019 Q2 | 41.21 Million USD | 813.07% |
2019 Q3 | 45.36 Million USD | 10.06% |
2019 Q4 | 46.62 Million USD | 2.78% |
2018 Q3 | 50.04 Million USD | -30.26% |
2018 Q1 | 56.83 Million USD | -40.89% |
2018 Q2 | 71.75 Million USD | 26.26% |
2018 Q4 | 41.25 Million USD | -17.57% |
2018 FY | 219.88 Million USD | -23.63% |
2017 Q2 | 79.8 Million USD | 21.99% |
2017 FY | 287.92 Million USD | -17.19% |
2017 Q4 | 96.15 Million USD | 106.55% |
2017 Q3 | 46.55 Million USD | -41.66% |
2017 Q1 | 65.41 Million USD | -38.49% |
2016 FY | 347.71 Million USD | -6.89% |
2016 Q4 | 106.34 Million USD | 11.09% |
2016 Q2 | 83.46 Million USD | 34.23% |
2016 Q3 | 95.72 Million USD | 14.7% |
2016 Q1 | 62.17 Million USD | -41.73% |
2015 Q3 | 90.75 Million USD | -0.51% |
2015 Q2 | 91.22 Million USD | 7.63% |
2015 Q4 | 106.69 Million USD | 17.56% |
2015 FY | 373.42 Million USD | 8.0% |
2015 Q1 | 84.75 Million USD | -8.47% |
2014 Q4 | 92.6 Million USD | -4.19% |
2014 Q2 | 75.22 Million USD | -7.45% |
2014 Q1 | 81.28 Million USD | -22.19% |
2014 FY | 345.75 Million USD | -2.45% |
2014 Q3 | 96.65 Million USD | 28.49% |
2013 Q3 | 89.53 Million USD | 14.99% |
2013 Q2 | 77.86 Million USD | -5.72% |
2013 Q1 | 82.59 Million USD | -19.7% |
2013 FY | 354.45 Million USD | -0.99% |
2013 Q4 | 104.45 Million USD | 16.66% |
2012 FY | 358 Million USD | -4.79% |
2012 Q1 | 81.99 Million USD | -21.26% |
2012 Q2 | 83.25 Million USD | 1.54% |
2012 Q3 | 89.9 Million USD | 7.98% |
2012 Q4 | 102.85 Million USD | 14.4% |
2011 Q3 | 92.7 Million USD | 2.83% |
2011 Q1 | 89.02 Million USD | -11.2% |
2011 Q2 | 90.15 Million USD | 1.27% |
2011 Q4 | 104.12 Million USD | 12.32% |
2011 FY | 376 Million USD | 5.83% |
2010 Q4 | 100.24 Million USD | 6.91% |
2010 Q1 | 76.79 Million USD | -16.97% |
2010 FY | 355.29 Million USD | 2.62% |
2010 Q3 | 93.76 Million USD | 10.99% |
2010 Q2 | 84.48 Million USD | 10.02% |
2009 Q3 | 91.54 Million USD | 10.82% |
2009 FY | 346.22 Million USD | -3.61% |
2009 Q1 | 79.59 Million USD | -21.4% |
2009 Q2 | 82.6 Million USD | 3.78% |
2009 Q4 | 92.48 Million USD | 1.03% |
2008 FY | 359.2 Million USD | 7.0% |
2008 Q1 | 75.2 Million USD | -22.02% |
2008 Q2 | 85.61 Million USD | 13.84% |
2008 Q3 | 97.11 Million USD | 13.43% |
2008 Q4 | 101.26 Million USD | 4.28% |
2007 Q4 | 96.44 Million USD | 4.06% |
2007 Q1 | 68.53 Million USD | -25.61% |
2007 Q2 | 78.02 Million USD | 13.84% |
2007 FY | 335.69 Million USD | 3.92% |
2007 Q3 | 92.68 Million USD | 18.8% |
2006 Q4 | 92.12 Million USD | 4.04% |
2006 Q3 | 88.54 Million USD | 21.59% |
2006 Q2 | 72.82 Million USD | 4.76% |
2006 Q1 | 69.51 Million USD | -15.94% |
2006 FY | 323.01 Million USD | 6.91% |
2005 FY | 302.13 Million USD | 24.59% |
2005 Q4 | 82.69 Million USD | 1.12% |
2005 Q3 | 81.77 Million USD | 16.73% |
2005 Q2 | 70.05 Million USD | 3.63% |
2005 Q1 | 67.6 Million USD | -8.92% |
2004 FY | 242.5 Million USD | 35.51% |
2004 Q4 | 74.22 Million USD | 10.79% |
2004 Q2 | 56.27 Million USD | 25.04% |
2004 Q3 | 66.99 Million USD | 19.04% |
2004 Q1 | 45 Million USD | -12.01% |
2003 FY | 178.94 Million USD | 21.58% |
2003 Q1 | 38.86 Million USD | -10.05% |
2003 Q2 | 42.45 Million USD | 9.25% |
2003 Q3 | 46.47 Million USD | 9.47% |
2003 Q4 | 51.15 Million USD | 10.05% |
2002 Q1 | 29.44 Million USD | -4.63% |
2002 Q4 | 43.2 Million USD | 11.98% |
2002 Q3 | 38.58 Million USD | 7.3% |
2002 Q2 | 35.95 Million USD | 22.13% |
2002 FY | 147.18 Million USD | 27.85% |
2001 Q3 | 30.82 Million USD | 6.25% |
2001 Q2 | 29 Million USD | 18.79% |
2001 FY | 115.11 Million USD | 17.05% |
2001 Q1 | 24.41 Million USD | -10.37% |
2001 Q4 | 30.86 Million USD | 0.16% |
2000 Q1 | 22.1 Million USD | 4.25% |
2000 Q4 | 27.24 Million USD | 3.59% |
2000 Q2 | 22.5 Million USD | 1.81% |
2000 FY | 98.34 Million USD | 25.6% |
2000 Q3 | 26.3 Million USD | 16.89% |
1999 Q2 | 18.7 Million USD | 13.33% |
1999 Q1 | 16.5 Million USD | -10.33% |
1999 Q4 | 21.2 Million USD | -2.75% |
1999 Q3 | 21.8 Million USD | 16.58% |
1999 FY | 78.3 Million USD | 19.91% |
1998 Q1 | 13.2 Million USD | -13.73% |
1998 Q3 | 17.3 Million USD | 9.49% |
1998 Q2 | 15.8 Million USD | 19.7% |
1998 FY | 65.3 Million USD | 26.8% |
1998 Q4 | 18.4 Million USD | 6.36% |
1997 Q4 | 15.3 Million USD | 6.25% |
1997 Q2 | 11.9 Million USD | 32.22% |
1997 Q1 | 9 Million USD | -31.82% |
1997 FY | 51.5 Million USD | 15.47% |
1997 Q3 | 14.4 Million USD | 21.01% |
1996 Q4 | 13.2 Million USD | 22.22% |
1996 FY | 44.6 Million USD | 14.36% |
1996 Q3 | 10.8 Million USD | 0.93% |
1996 Q2 | 10.7 Million USD | 11.46% |
1996 Q1 | 9.6 Million USD | -15.79% |
1995 Q2 | 9.3 Million USD | 10.71% |
1995 Q3 | 9.5 Million USD | 2.15% |
1995 Q4 | 11.4 Million USD | 20.0% |
1995 FY | 39 Million USD | 21.12% |
1995 Q1 | 8.4 Million USD | -13.4% |
1994 Q3 | 7.7 Million USD | -4.94% |
1994 Q4 | 9.7 Million USD | 25.97% |
1994 FY | 32.2 Million USD | 58.62% |
1994 Q1 | 6.7 Million USD | 42.55% |
1994 Q2 | 8.1 Million USD | 20.9% |
1993 Q4 | 4.7 Million USD | -2.08% |
1993 FY | 20.3 Million USD | 50.37% |
1993 Q1 | 81.9 Million USD | 143.43% |
1993 Q2 | 5.4 Million USD | -93.41% |
1993 Q3 | 4.8 Million USD | -11.11% |
1992 Q4 | -188.6 Million USD | -373.33% |
1992 FY | 13.5 Million USD | 19.47% |
1992 Q1 | 63.3 Million USD | 138.09% |
1992 Q2 | 69.8 Million USD | 10.27% |
1992 Q3 | 69 Million USD | -1.15% |
1991 FY | 11.3 Million USD | 0.0% |
1991 Q1 | 57.4 Million USD | 0.0% |
1991 Q2 | 60.6 Million USD | 5.57% |
1991 Q3 | 59.6 Million USD | -1.65% |
1991 Q4 | -166.2 Million USD | -378.86% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Phreesia, Inc. | -131.77 Million USD | 291.939% |
Accuray Incorporated | 504 Thousand USD | -50083.333% |
Align Technology, Inc. | 643.33 Million USD | 60.686% |
Elevance Health Inc. | 133.96 Billion USD | 99.811% |
AxoGen, Inc. | -21.46 Million USD | 1278.474% |
Boston Scientific Corporation | 2.34 Billion USD | 89.205% |
CVS Health Corporation | 13.74 Billion USD | 98.16% |
Cardinal Health, Inc. | 1.24 Billion USD | 79.652% |
Centene Corporation | 2.93 Billion USD | 91.368% |
DaVita Inc. | 1.6 Billion USD | 84.22% |
HCA Healthcare, Inc. | 9.62 Billion USD | 97.373% |
Hologic, Inc. | 970.2 Million USD | 73.931% |
Humana Inc. | 4.01 Billion USD | 93.697% |
IDEXX Laboratories, Inc. | 1.09 Billion USD | 76.947% |
Laboratory Corporation of America Holdings | 725.6 Million USD | 65.143% |
Masimo Corporation | 136.5 Million USD | -85.292% |
McKesson Corporation | 3.9 Billion USD | 93.53% |
Quest Diagnostics Incorporated | 1.26 Billion USD | 79.958% |
ResMed Inc. | 1.31 Billion USD | 80.838% |
Henry Schein, Inc. | 615 Million USD | 58.874% |
Teladoc Health, Inc. | -248.55 Million USD | 201.759% |
Universal Health Services, Inc. | 1.17 Billion USD | 78.482% |
Veeva Systems Inc. | 429.33 Million USD | 41.089% |
Baxter International Inc. | 390 Million USD | 35.148% |
Becton, Dickinson and Company | 2.11 Billion USD | 88.019% |
Intuitive Surgical, Inc. | 1.76 Billion USD | 85.685% |
Danaher Corporation | 5.38 Billion USD | 95.3% |
Stryker Corporation | 3.88 Billion USD | 93.495% |
Medtronic plc | 5.14 Billion USD | 95.083% |